Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 12/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.33 |
| ▸ | F11 | P03951 | 1/20 | 0.32 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.32 |
| ▸ | STS | P08842 | 1/20 | 0.32 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.32 |
| ▸ | ABL1 | P00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710102 | 0.91 | GRIK1 (0.35) | HIF1AGRIK1KMT2ACNR2ROCK1 | |
| SCHEMBL6710358 | 0.89 | HIF1A (0.34) | HIF1ACNR2STSSERPINE1 | |
| SCHEMBL6710345 | 0.88 | ENPP3 (0.42) | HIF1AGRIK1 | |
| SCHEMBL6713299 | 0.88 | HIF1A (0.43) | HIF1AGRIK1 | |
| SCHEMBL6710302 | 0.86 | HIF1A (0.43) | HIF1AGRIK1NPC1ROCK1 | |
| SCHEMBL6708058 | 0.84 | ENPP3 (0.36) | HIF1ANPC1HSP90AA1AGTR1KMT2A | |
| SCHEMBL6709014 | 0.83 | HIF1A (0.48) | HIF1AGRIK1NPC1KMT2A | |
| SCHEMBL6709033 | 0.83 | HIF1A (0.49) | HIF1AGRIK1KMT2AROCK1F11 | |
| SCHEMBL6707716 | 0.81 | HIF1A (0.43) | HIF1AGRIK1NPC1ROCK1 | |
| SCHEMBL6713562 | 0.81 | HIF1A (0.41) | HIF1AGRIK1NPC1KMT2AF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | HIF1A 296/4885GRIK1 3885/4885NPC1 3891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.